Zinc Plasma Levels in Recurrent Vulvovaginal Candidiasis Patients
Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2017 Background: Recurrent vulvovaginal candidiasis (RVVC) is episodes of thrush vulvovaginalis 4 times or more within 12 months. Some exogenous pathogenic factors and host are known to be associated with RVVC including sex hormones, contraceptives, obesity,
Deryne Anggia Paramita +2 more
doaj +3 more sources
Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India. [PDF]
, 2012 BACKGROUND: Vulvovaginal candidiasis is characterized by curd-like vaginal discharge and itching, and is associated with considerable health and economic costs.
Madhivanan, Purnima +9 more
core +3 more sources
Psychosocial impact of recurrent urogenital infections: a review
Women's Health, 2023 Recurrent urogenital infections such as bacterial vaginosis, vulvovaginal candidiasis, and urinary tract infections have a high prevalence and pronounced psychosocial impact. However, no review has compared the psychosocial impacts across infection types.
Krystal Thomas-White +5 more
doaj +1 more source
Use of Povidone Iodine Vaginal Swabbing in Treatment of Recurrent Vulvovaginal Candidiasis [PDF]
International Journal of Medical Arts, 2023 Background: Recurrent vulvovaginal candidiasis [RVVC] is a common condition affecting millions of women worldwide. It is associated with significant morbidity.
Shimaa Younis +2 more
doaj +1 more source
, 2021 Recurrent vulvovaginal candidiasis (RVVC) is a subtype of vulvovaginal candidiasis, with debilitating effects on physical and emotional well-being affecting up to 10% of Australian women.
Evelin Tiralongo +9 more
core +1 more source
Cellular immunity in recurrent vulvovaginal candidiasis [PDF]
Clinical and Experimental Immunology, 1998 SUMMARYImpaired T cell function has been reported to predispose women to recurrent vulvovaginal candidiasis, but conflicting results have been noted in the literature. Most clinical episodes occur in the late luteal phase, suggesting hormonal influence on host resistance.
Corrigan, E. M. +4 more
openaire +3 more sources
β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis. [PDF]
PLoS ONE, 2014 Vulvovaginal candidiasis (VVC) is among the most prevalent vaginal diseases. Candida albicans is still the most prevalent species associated with this pathology, however, the prevalence of other Candida species, such as C. glabrata, is increasing.
Patricia de Souza Bonfim-Mendonça +9 more
doaj +1 more source
Investigation of the relationship between different Candida species and some risk factors affecting the incidence of Vulvovaginal Candidiasis [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2019 Introduction: Vulvovaginal candidiasis (VVC) is a yeast infection and is one of the most common causes of women's referral to the physician. The aim of this study was to investigate the relationship between different Candida species and some risk factors
Seyedeh Sedigheh Hosseini +11 more
doaj +1 more source
Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates
PLoS ONE, 2020 Objectives Recurrent vulvovaginal candidiasis (RVVC) causes significant morbidity. Candida albicans is the main pathogen associated with both sporadic and recurrent candidiasis.
Cathrin Alvendal +4 more
doaj +2 more sources
The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
Медицинский совет, 2016 The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases.
V. N. Serov +3 more
doaj +1 more source